GlassScriptPhysician profile
Donella Jenkins
NPI 1942203609
$1,014.52
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.75 · 2020: $59.27 · 2021: $430 · 2022: $496 · 2023: $13.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13.41.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $628.29 | 2021-2022 | |
| Lilly USA, LLC | $44.94 | 2020-2022 | |
| Abbvie INC. | $39.16 | 2021 | |
| Merck Sharp & Dohme LLC | $37.33 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.62 | 2022-2023 | |
| Mannkind Corporation | $30.45 | 2021 | |
| Medtronic, INC. | $28.89 | 2022 | |
| Neurocrine Biosciences, INC. | $25.74 | 2022 | |
| Glaxosmithkline, LLC. | $23.94 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $23.93 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $20.24 | 2022 | |
| Abbott Laboratories | $19.69 | 2021 | |
| Novo Nordisk INC | $16.06 | 2022 | |
| Medtronic Vascular, INC. | $15.75 | 2019 | |
| Allergan, INC. | $14.79 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $11.70 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donella Jenkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.